The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Identification and Functional Characterization of a Na+-independent Neutral Amino Acid Transporter with Broad Substrate Selectivity
Open accessAbstract
We have isolated a cDNA from rat small intestine that encodes a novel Na+-independent neutral amino acid transporter with distinctive characteristics in substrate selectivity and transport property. The encoded protein, designated L-type amino acid transporter-2 (LAT-2), shows amino acid sequence similarity to the system L Na+-independent neutral amino acid transporter LAT-1 (Kanai, Y., Segawa, H., Miyamoto, K., Uchino, H., Takeda, E., and Endou, H. (1998) J. Biol. Chem. 273, 23629-23632) (50% identity) and the system y+L transporters y+LAT-1 (47%) and KIAA0245/y+LAT-2 (45%) (Torrents, D., Estevez, R., Pineda, M., Fernandez, E., Lloberas, J., Shi, Y.-B., Zorzano, A., and Palacin, M. (1998) J. Biol. Chem. 273, 32437-32445). LAT-2 is a nonglycosylated membrane protein. It requires 4F2 heavy chain, a type II membrane glycoprotein, for its functional expression in Xenopus oocytes. LAT-2-mediated transport is not dependent on Na+ or Cl- and is inhibited by a system L-specific inhibitor, 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), indicating that LAT-2 is a second isoform of the system L transporter. Compared with LAT-1, which prefers large neutral amino acids with branched or aromatic side chains, LAT-2 exhibits remarkably broad substrate selectivity. It transports all of the L-isomers of neutral alpha-amino acids. LAT-2 exhibits higher affinity (Km = 30-50 microM) to Tyr, Phe, Trp, Thr, Asn, Ile, Cys, Ser, Leu, Val, and Gln and relatively lower affinity (Km = 180-300 microM) to His, Ala, Met, and Gly. In addition, LAT-2 mediates facilitated diffusion of substrate amino acids, as distinct from LAT-1, which mediates amino acid exchange. LAT-2-mediated transport is increased by lowering the pH level, with peak activity at pH 6.25, because of the decrease in the Km value without changing the Vmax value. Because of these functional properties and a high level of expression of LAT-2 in the small intestine, kidney, placenta, and brain, it is suggested that the heterodimeric complex of LAT-2 and 4F2 heavy chain is involved in the trans-cellular transport of neutral amino acids in epithelia and blood-tissue barriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An analysis of vertebrate mRNA sequences: intimations of translational control.
Kozak, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.4.887 · Cited by 1,635
Primary structure and functional characterization of a high-affinity glutamate transporter
Kanai, Y., & Hediger, M. A. (1992) · Nature · doi:10.1038/360467a0 · Cited by 1,332
Self-citationKanai, Y., Segawa, H., Miyamoto, K.-I., Uchino, H., Takeda, E., & Endou, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23629 · Cited by 1,109
Self-citationRole of amino acid transport and countertransport in nutrition and metabolism.
Christensen, H. N. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.1.43 · Cited by 1,099
Expression cloning of a mammalian proton-coupled oligopeptide transporter
Fei, Y.-J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F. H., Romero, M. F., Singh, S. K., Boron, W. F., & Hediger, M. A. (1994) · Nature · doi:10.1038/368563a0 · Cited by 891
Self-citationDistinct Mediating Systems for the Transport of Neutral Amino Acids by the Ehrlich Cell
Oxender, D. L., & Christensen, H. N. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75327-7 · Cited by 835
Molecular Biology of Mammalian Plasma Membrane Amino Acid Transporters
PALACÍN, M., ESTÉVEZ, R., BERTRAN, J., & ZORZANO, A. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.969 · Cited by 823
Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family
Mastroberardino, L., Spindler, B., Pfeiffer, R., Skelly, P. J., Loffing, J., Shoemaker, C. B., & Verrey, F. (1998) · Nature · doi:10.1038/26246 · Cited by 557
Utsunomiya-Tate, N., Endou, H., & Kanai, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14883 · Cited by 529
Self-citation
Cited by
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
SULFUR AMINO ACID METABOLISM: Pathways for Production and Removal of Homocysteine and Cysteine
Stipanuk, M. H. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132418 · Cited by 995
Amino Acid Transport Across Mammalian Intestinal and Renal Epithelia
Bröer, S. (2008) · Physiological Reviews · doi:10.1152/physrev.00018.2006 · Cited by 958
Yanagida, O., Kanai, Y., Chairoungdua, A., Kim, D. K., Segawa, H., Nii, T., Cha, S. H., Matsuo, H., Fukushima, J.-I., Fukasawa, Y., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00384-4 · Cited by 746
Self-citationAmino acid homeostasis and signalling in mammalian cells and organisms
Bröer, S., & Bröer, A. (2017) · Biochemical Journal · doi:10.1042/bcj20160822 · Cited by 502
Selective expression of the large neutral amino acid transporter at the blood–brain barrier
Boado, R. J., Li, J. Y., Nagaya, M., Zhang, C., & Pardridge, W. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12079 · Cited by 481
Structure of the Blood–Brain Barrier and Its Role in the Transport of Amino Acids
Hawkins, R. A., O’Kane, R. L., Simpson, I. A., & Viña, J. R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.1.218s · Cited by 453
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Mann, G. E., Yudilevich, D. L., & Sobrevia, L. (2003) · Physiological Reviews · doi:10.1152/physrev.00022.2002 · Cited by 430
Uchino, H., Kanai, Y., Kim, D. K., Wempe, M. F., Chairoungdua, A., Morimoto, E., Anders, M. W., & Endou, H. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12322-x · Cited by 421
Self-citationCancer progression by reprogrammed BCAA metabolism in myeloid leukaemia
Hattori, A., Tsunoda, M., Konuma, T., Kobayashi, M., Nagy, T., Glushka, J., Tayyari, F., McSkimming, D., Kannan, N., Tojo, A., et al. (2017) · Nature · doi:10.1038/nature22314 · Cited by 401
Hennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0435 · Cited by 394
A guide to plasma membrane solute carrier proteins
Pizzagalli, M. D., Bensimon, A., & Superti‐Furga, G. (2021) · The FEBS Journal · doi:10.1111/febs.15531 · Cited by 379
Transporter-Mediated Permeation of Drugs Across the Blood–Brain Barrier
Tamai, I., & Tsuji, A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1371::aid-jps1>3.0.co;2-d · Cited by 363
Function and structure of heterodimeric amino acid transporters
Wagner, C. A., Lang, F., & Bröer, S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.4.c1077 · Cited by 357
Transfer of glutamine between astrocytes and neurons
Bröer, S., & Brookes, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00322.x · Cited by 325
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy
Zhai, L., Spranger, S., Binder, D. C., Gritsina, G., Lauing, K. L., Giles, F. J., & Wainwright, D. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0420 · Cited by 322
Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
del Amo, E. M., Urtti, A., & Yliperttula, M. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.015 · Cited by 319
Activation of system L heterodimeric amino acid exchangers by intracellular substrates
Meier, C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.580 · Cited by 314
Growth-related Renal Type II Na/Pi Cotransporter
Segawa, H., Kaneko, I., Takahashi, A., Kuwahata, M., Ito, M., Ohkido, I., Tatsumi, S., & Miyamoto, K.-I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200943200 · Cited by 304
Self-citationCloning and Functional Identification of a Neuronal Glutamine Transporter
Varoqui, H., Yao, D., Zhu, H., Ming, H., & Erickson, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4049 · Cited by 301
The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier
Kageyama, T., Nakamura, M., Matsuo, A., Yamasaki, Y., Takakura, Y., Hashida, M., Kanai, Y., Naito, M., Tsuruo, T., Minato, N., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02758-x · Cited by 298
Self-citationFukasawa, Y., Segawa, H., Kim, J. Y., Chairoungdua, A., Kim, D. K., Matsuo, H., Cha, S. H., Endou, H., & Kanai, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9690 · Cited by 285
Self-citationSystem L: heteromeric exchangers of large, neutral amino acids involved in directional transport
Verrey, F. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0973-z · Cited by 284
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics
Kanai, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107964 · Cited by 283
Self-citationl‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
Oda, K., Hosoda, N., Endo, H., Saito, K., Tsujihara, K., Yamamura, M., Sakata, T., Anzai, N., Wempe, M. F., Kanai, Y., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01386.x · Cited by 273
Self-citationBlood-brain barrier transport machineries and targeted therapy of brain diseases
Barar, J., Rafi, M. A., Pourseif, M. M., & Omidi, Y. (2016) · BioImpacts · doi:10.15171/bi.2016.30 · Cited by 257
Groeneweg, S., van Geest, F. S., Peeters, R. P., Heuer, H., & Visser, W. E. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz008 · Cited by 216
O'Kane, R. L., & Hawkins, R. A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00193.2003 · Cited by 105
“Transport was Na dependent, voltage sensitive, and inhibited by 2-aminobicyclo(2,2,1)-heptane-2-carboxylic acid, a particular inhibitor of the facilitative large neutral amino acid transporter 1 (LAT1) system.”
BackgroundInfluentialThe actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes
Gran, P., & Cameron-Smith, D. (2011) · BMC Physiology · doi:10.1186/1472-6793-11-10 · Cited by 95
Transport of Iodothyronines by Human L-Type Amino Acid Transporters
Zevenbergen, C., Meima, M. E., Lima de Souza, E. C., Peeters, R. P., Kinne, A., Krause, G., Visser, W. E., & Visser, T. J. (2015) · Endocrinology · doi:10.1210/en.2015-1140 · Cited by 55
Krause, G., & Hinz, K. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.018 · Cited by 27
Putative roles of SLC7A5 (LAT1) transporter in pain
Alles, S. R. A., Gomez, K., Moutal, A., & Khanna, R. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100050 · Cited by 16
Metadata
- Authors
- Segawa, H., Fukasawa, Y., Miyamoto, K.-I., Takeda, E., Endou, H., & Kanai, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-07
- Volume
- 274
- Issue
- 28
- Pages
- 19745-19751
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2023253424
- Cited by
- 498
- References
- 37
- FWCI
- 13.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.